Market Place
Sourcing Support
Galderma receives +ve outcome through EU Decentralised Procedure for AKLIEF
20 Dec 2019 //
BUSINESSWIRE
Galderma Acne treatment receives approval from Europe
20 Dec 2019 //
PHARMAFILE
Galderma Demonstrates Robust Aesthetic Innovation Pipeline with Initiation
24 Oct 2019 //
PR NEWSWIRE
Galderma Advances Phase 3 Clinical Study with Nemolizumab
09 Oct 2019 //
BUSINESSWIRE
Galderma Announces Positive Phase 2 Results forBotulinum Toxin a
09 Oct 2019 //
PRNEWS WIRE
Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream, 0.005%
04 Oct 2019 //
PR NEWSWIRE
Galderma Presented Final Results from Phase 2b Study of Nemolizumab
08 Mar 2019 //
BUSINESSWIRE
Soolantra® ( (Ivermectin): Galderma Lab v. Actavis Lab Teva Pharma USA
11 Dec 2017 //
PATENT LITIGATION
Soolantra® (ivermectin): Galderma Laboratories, v. Perrigo UK FINCO
13 Jul 2017 //
PATENT LITIGATION
Soolantra® (Ivermectin): Galderma Laboratories,Nestle Skin Health & Actavis & Teva Inc.
21 Apr 2017 //
PATENT LITIGATION
Chugai grants exclusive global license for development of nemolizumab
21 Jul 2016 //
PHARMABIZ
Galderma Celebrates 20th Global Anniversary of Restylane®
10 Jun 2016 //
PR NEWSWIRE
Dermatology Company Galderma Laboratories Expands HQ
11 May 2016 //
BIOSPACE
Galderma acquires exclusive rights to develop,distribute Ipsen`s Dysport
07 Jan 2016 //
PHARMABIZ
Five medicines cleared for use by NHS Scotland
07 Dec 2015 //
PHARMATIMES
Exclusive: U.S. drug benefit managers clamp down on specialty pharmacies
16 Nov 2015 //
REUTERS
Irmat Pharmacy says faces termination by UnitedHealth`s OptumRx
13 Nov 2015 //
REUTERS
FDA asks dermal filler makers to indicate risk of serious injury
29 May 2015 //
REUTERS
FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex`s Kaldeco
11 Mar 2015 //
RAPS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.